Holen Sie sich die Stockscreener-App
0.134
2.19%
-0.003
Handel nachbörslich:
.13
-0.004
-2.99%
Schlusskurs vom Vortag:
$0.137
Offen:
$0.1322
24-Stunden-Volumen:
2.29M
Relative Volume:
0.95
Marktkapitalisierung:
$16.00M
Einnahmen:
$436.97M
Nettoeinkommen (Verlust:
$-35.62M
KGV:
-0.4492
EPS:
-0.2983
Netto-Cashflow:
$-10.71M
1W Leistung:
-22.90%
1M Leistung:
-41.74%
6M Leistung:
-71.33%
1J Leistung:
-91.68%
1-Tages-Spanne:
$0.1252
$0.1368
1-Wochen-Bereich:
$0.1252
$0.168
52-Wochen-Spanne:
$0.1252
$1.65
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.134 | 16.00M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray Incorporated (ARAY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026 - TradingView
Accuray Inc. R (XEJ.DU) Q3 FY2026 earnings call transcript - Yahoo Finance
Accuray Inc. R (XEJ.DU) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 4 Accuray Incorporated: Ali Pervaiz (SVP Chief Financial Officer) For: 23 September - Investing.com Nigeria
Accuray Inc : Jefferies Raises Target Price t - Moomoo
Accuray Incorporated Announces Mika Nishimura Not to Stand for Re-Election as Board of Directors - www.marketscreener.com
Accuray Director Richard Meier Awarded 75,000 RSUs and Stock Options in October 2026 - Kalkine Media
Accuray Announces Stockholder Approval of Key - Moomoo
Accuray Inc (ARAY) Stockholders Approve Key Financing and Revers - GuruFocus
Accuray appoints Richard A. Meier to Board and Compensation Committee - TradingView
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - PR Newswire
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director - TradingView
Accuray Incorporated Announces Appointment of Richard A. ("Randy") Meier as Director and Compensation Committee Member, Effective October 6, 2026 - www.marketscreener.com
XEJ Forecast — Price Target — Prediction for 2027 - TradingView
Japan Approves Accuray’s Cyberknife M6 System for Radiation Therapy Patients - mpo-mag.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Accuray shares jump as Samsung NeuroLogica collaboration update sparks rally - Quiver Quantitative
Accuray Incorporated Stock Analysis: Bearish Trends and Key Levels Near Term - The Cryptonomist
Why Is Accuray Stock Gaining Monday? - Benzinga
Why Is Accuray Stock Gaining Monday? - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why is Accuray Incorporated Stock (ARAY) Up 60% Today? - TipRanks
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - Medical Device Network
Accuray partners with Samsung NeuroLogica on CyberKnife imaging - finance.yahoo.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - Investing News Network
Accuray (ARAY) Partners with Samsung HME America to Advance Cybe - GuruFocus
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - PR Newswire
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - cherokeephoenix.org
Accuray Incorporated (ARAY) Partners With Samsung NeuroLogica on Volumetric Imaging for CyberKnife - tradingview.com
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform - WAOW
Accuray Incorporated (ARAY) options chain - Yahoo Finance UK
ACCURAY INC SEC Filing (Sep 14, 2026) - Stock Titan
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - PR Newswire
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - Investing News Network
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Accuray Inc-Aktie (ARAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
| Kill Robert | Former Director |
Dec 22 '25 |
Proposed Sale |
0.92 |
262,809 |
241,784 |
0 |
| Chew Jesse | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
19,993 |
20,393 |
0 |
| Winter Suzanne C | Officer |
Dec 01 '25 |
Proposed Sale |
1.02 |
68,058 |
69,419 |
0 |
| Pervaiz Ali | SVP Chief Financial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
44,025 |
0 |
410,204 |
| Chalke Sandeep | SVP, Chief Commercial Officer |
Nov 29 '25 |
Option Exercise |
0.00 |
50,314 |
0 |
524,283 |
2.15%
5.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):